Small drugmakers seek deadline extension for GMP compliance as December 2025 approaches, emphasizing the need for support and ...

Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...

The health ministry is unlikely to extend the Schedule M deadline for MSME pharma firms beyond December 31, 2025, as it ...

Notified in December 2023, the revised Schedule M has shifted the focus from “good manufacturing practices” to “good ...

Multiple departments, including engineering and quality assurance, are responsible for evaluating GMP equipment and ...

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Golden Rules of Being a Successful GMP (Good Manufacturing Practice) Auditor Training Course (Feb 5th - Feb 6th, 2026)" training has been added to ...

As the year draws to a close, medium and small drugmakers in India have a deadline coming up in less than two months as the country moves to secure the production of safe and quality medicines. After ...

Subject to TSX Venture Exchange (“ TSXV ”) approval, NurExone has engaged Russo Partners LLC, a New York–based strategic communications firm, (“ Russo ”) for an initial consulting project for up to ...

Dr Reddy's Laboratories informed the stock exchanges on December 12, 2025, about the conclusion of the inspection.